JVAs Q1 Earnings Jump 42.9% Tariffs and Efficiency Fuel the Surge
Coffee Holding Co. (JVA) delivered a standout performance in fiscal 2026 Q1, with revenue and earnings growth exceeding expectations. The company reported a 20% year-over-year revenue increase to $25.57 million and a 42.9% jump in net income to $1.65 million. Management emphasized operational efficiencies and reduced tariffs as key drivers, while forward-looking guidance remained optimistic without specific targets.
Revenue

The total revenue of Coffee HoldingJVA-- increased by 20.0% to $25.57 million in 2026 Q1, up from $21.31 million in 2025 Q1.
Earnings/Net Income
Coffee Holding's EPS rose 45.0% to $0.29 in 2026 Q1 from $0.20 in 2025 Q1, marking continued earnings growth. Meanwhile, the company's profitability strengthened with net income of $1.65 million in 2026 Q1, marking 42.9% growth from $1.15 million in 2025 Q1. Remarkably, in 2026 Q1, the company set a new record high for fiscal Q1 net income, the highest in 20 years. The earnings growth outperformed expectations, reflecting strong operational execution.
Price Action
The stock price of Coffee Holding has edged up 0.63% during the latest trading day, has edged up 0.63% during the most recent full trading week, and has edged down 0.63% month-to-date.
Post-Earnings Price Action Review
The strategy of buying Coffee Holding (JVA) shares on the date of its revenue raise and holding for 30 days yielded positive returns over the past three years. The cumulative profit reached $0.95, with a compound annual growth rate (CAGR) of 21.8%, outperforming the broader market. This indicates a robust momentum-based strategy for JVAJVA--, aligning with its positive earnings trajectory and market sentiment. Conclusion: The strategy of purchasing JVA shares on the revenue raise date and holding for 30 days has been profitable over the past three years, highlighting the stock's potential for short-term gains following positive earnings announcements. This approach can be considered for investors looking to capitalize on the company's growth prospects and market momentum. Note: The simulation assumes reinvestment of dividends and does not account for transaction fees, which may impact actual returns.
CEO Commentary
Andrew Gordon, President & CEO, highlighted a 20% revenue increase ($25.566M vs. $21.305M) driven by reduced tariff expenses and operational efficiency from consolidating east coast manufacturing. He emphasized strong sales across private label, branded, and green bean segments, while acknowledging ongoing coffee market volatility and macroeconomic challenges. The tone was cautiously optimistic, with confidence in core business strength and shareholder returns despite external uncertainties.
Guidance
The Company expects continued positive results for shareholders, citing strong core business performance and operational efficiencies, though no specific revenue or EPS targets were provided. Forward-looking statements referenced product demand, market acceptance, and economic conditions as key variables, with no quantified guidance beyond general optimism about future performance.
Additional News
Coffee Holding recently completed the acquisition of Empire Coffee Company’s assets through its Second Empire subsidiary, expanding its wholesale coffee portfolio. The company also announced the closure of its Comfort Foods manufacturing facility in North Andover, Massachusetts, with production shifting to its Port Chester, New York facility to consolidate operations. Earlier in 2025, Coffee Holding terminated a proposed merger and share exchange agreement with Delta Corp Holdings Limited, opting to focus on organic growth and debt reduction. These strategic moves underscore the company’s commitment to optimizing its manufacturing footprint and enhancing shareholder value.
Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet